Immunic (IMUX) Times Interest Earned (2013 - 2026)
Immunic (IMUX) posted Times Interest Earned of -$9.98 for Q1 2026, down 5027.46% sequentially from -$0.19 in Q4 2025, and up 99.38% YoY from -$5.0 in Q1 2025.
Immunic (IMUX) Times Interest Earned (2013 - 2026) Analysis & Trends
Immunic has reported Times Interest Earned for 14 years, with the latest figure at -$9.98 in Q1 2026.
- Quarterly Times Interest Earned rose 99.38% year-over-year to -$9.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$32.92 (up 99.46% YoY) and the FY2025 annual result came in at -$0.86, down 2.82% from the prior year.
- Times Interest Earned declined to -$9.98 in Q1 2026 per IMUX's latest filing, from -$0.19 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.19 in Q4 2025 and troughed at -$12167.5 in Q2 2024.
- A 5-year average of -$1442.3 and a median of -$51.67 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 285644.41% in 2024, then soared 99.97% in 2025.
- Over 5 years, Times Interest Earned stood at -$0.78 in 2022, then surged by 69.92% to -$0.24 in 2023, then tumbled by 285644.41% to -$674.5 in 2024, then jumped by 99.97% to -$0.19 in 2025, then sank by 5027.46% to -$9.98 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$9.98, -$0.19, and -$24.55 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | -1.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.50 |
| Mar 31, 2026 | -9.98 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -24.55 |
| Jun 30, 2025 | -330.28 |
| Mar 31, 2025 | -1,612.56 |
| Dec 31, 2024 | -674.50 |
| Sep 30, 2024 | -9.21 |
| Jun 30, 2024 | -12,167.47 |
| Mar 31, 2024 | -51.67 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -196.92 |
| Jun 30, 2023 | -11.53 |
| Mar 31, 2023 | -168.81 |
| Dec 31, 2022 | -0.78 |
| Sep 30, 2022 | -8,381.67 |
| Jun 30, 2022 | -863.43 |
| Mar 31, 2022 | -14.64 |
| Dec 31, 2021 | -2,413.44 |
| Sep 30, 2021 | -246.94 |